NEW YORK (GenomeWeb News) – Becton Dickinson today said that its fiscal second-quarter revenues were up almost 4 percent year over year, helped along by a 5 percent increase in the BD Diagnostics segment.

The Franklin Lakes, NJ-based company reported revenues of $2.00 billion for the three months ended March 31, compared to $1.93 billion a year ago, and just beating the consensus Wall Street estimate of $1.99 billion. On a currency-neutral basis, revenues were up a little more than 4 percent, BD said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.